| 283 |
Antiplatelets Only Not Sufficient: Still Room for NOAC |
Jean-Philippe Collet |
Apr. 12. 21 |
| 282 |
What Should We Care About During the MitraClip Procedure? |
Geon-Jae Lee |
Apr. 12. 21 |
| 281 |
TAVAR for Bicuspid Valve |
Dong Joon Lee |
Apr. 12. 21 |
| 280 |
Optimal Deployment Projection of TAVAR |
Seung Yong Lee |
Apr. 12. 21 |
| 279 |
Focus on the Patient Outcomes that Truly Matter: Clinical Perspective Update |
Rebecca Hahn |
Apr. 12. 21 |
| 278 |
Delivering the Outcomes You Demand with SAPIEN 3 |
Jee-Hoon Kang |
Apr. 12. 21 |
| 277 |
My Experience of TAVR Using Cusp Overlap View for Self-Expanding THV |
Cheol Woong Yu |
Apr. 12. 21 |
| 276 |
TAVR Failure Due to Structural Valve Degeneration |
Vinayak Bapat |
Apr. 12. 21 |
| 275 |
My Experience Focusing on Cusp Overlap View |
Ju Han Kim |
Apr. 12. 21 |
| 274 |
How to Reduce PPI Rate with Cusp Overlap Technique |
Hemal Gada |
Apr. 12. 21 |
